These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15792733)

  • 21. Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil.
    Daher EF; Fonseca PP; Gerhard ES; Leitão TM; Silva Júnior GB
    J Parasitol; 2009 Jun; 95(3):652-5. PubMed ID: 19642802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kala Azar and HIV.
    Shahi SK; Ranga S; Khurana SK; Talib VH
    Indian J Pathol Microbiol; 1998 Jul; 41(3):269-70. PubMed ID: 9805846
    [No Abstract]   [Full Text] [Related]  

  • 23. Long term failure of miltefosine in the treatment of refractory visceral leishmaniasis in AIDS patients.
    Troya J; Casquero A; Refoyo E; Fernández-Guerrero ML; Górgolas M
    Scand J Infect Dis; 2008; 40(1):78-80. PubMed ID: 17852921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haematological manifestation of HIV infection.
    Ranga S; Prakash I; Khurana SK; Talib VH
    Indian J Pathol Microbiol; 1997 Jul; 40(3):417-31. PubMed ID: 9354022
    [No Abstract]   [Full Text] [Related]  

  • 25. [Visceral leishmaniasis in patients with HIV infection. Our experience].
    Terra L; Pellicanò S; Allò M
    Minerva Med; 1996 Jun; 87(6):317-9. PubMed ID: 8700361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences.
    Ali A
    Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Visceral leishmaniasis located in the intestines in patients with human immunodeficiency virus infection: a report of 2 cases].
    Roig P; Cuadrado JM; Benéitez C; Mayol MJ; López M; Navarro V; Nieto A; Bernacer B
    Rev Clin Esp; 1993 Apr; 192(6):271-3. PubMed ID: 8497722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fever of unknown origin in patients with HIV infection].
    Riera M; Altés J; Homar F; Picco G; Salas A; Leyes M; Cifuentes C; Artigues A; Villalonga C
    Enferm Infecc Microbiol Clin; 1996 Dec; 14(10):581-5. PubMed ID: 9052998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS).
    Pourahmad M; Hooshmand F; Rahiminejad M
    Int J Dermatol; 2009 Jan; 48(1):59-61. PubMed ID: 19126052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visceral leishmaniasis emerging as an important opportunistic infection in HIV-infected persons living in areas nonendemic for Leishmania donovani.
    Albrecht H; Sobottka I; Emminger C; Jablonowski H; Just G; Stoehr A; Kubin T; Salzberger B; Lutz T; van Lunzen J
    Arch Pathol Lab Med; 1996 Feb; 120(2):189-98. PubMed ID: 8712898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Visceral leishmaniasis in patient with HIV infection].
    Olea P; Pinilla J
    Rev Chilena Infectol; 2013 Apr; 30(2):216-20. PubMed ID: 23677161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Atypical presentation and fatal evolution of visceral leishmaniasis in a patient infected with HIV].
    Muńiz Grijalvo O; Losada Vińau J; Rizo Valero A; Miranda Guisado ML
    Rev Clin Esp; 1991 Jul; 189(3):151-2. PubMed ID: 1947393
    [No Abstract]   [Full Text] [Related]  

  • 33. Liposomal amphotericin B as first line and secondary prophylactic treatment for visceral leishmaniasis in a patient infected with HIV.
    Borrelli P; Imperato A; Murdaca G; Scudeletti M
    Ann Ital Med Int; 2000; 15(2):169-71. PubMed ID: 10920508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Visceral leishmaniasis and HIV infection].
    Pieltain Alvarez-Arenas R; Audibert Mena L; Pérez Mochales J; Tewfick M; Ortiz Alonso FJ; de Miguel Novoa MP
    Rev Clin Esp; 1991 Jul; 189(3):150. PubMed ID: 1947391
    [No Abstract]   [Full Text] [Related]  

  • 35. [Usefulness of percutaneous hepatic biopsy in patients with HIV infections].
    García Ordóñez MA; Lozano Serrano A; Muñoz Roca N; Juárez Fernández C
    An Med Interna; 1999 Oct; 16(10):543. PubMed ID: 10603678
    [No Abstract]   [Full Text] [Related]  

  • 36. Guidelines for visceral leishmaniasis and HIV co-infection.
    Burki T
    Lancet Infect Dis; 2022 Aug; 22(8):1124-1125. PubMed ID: 35870462
    [No Abstract]   [Full Text] [Related]  

  • 37. Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis.
    Donaghy L; Gros F; Amiot L; Mary C; Maillard A; Guiguen C; Gangneux JP
    Clin Exp Immunol; 2007 Feb; 147(2):236-40. PubMed ID: 17223963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary prophylaxis for visceral leishmaniasis in HIV-infected individuals.
    Pérez-Molina JA; López-Vélez ; Guerrero A
    Am J Med; 1997 Jan; 102(1):132. PubMed ID: 9209216
    [No Abstract]   [Full Text] [Related]  

  • 39. [The clinical impact of symptomatic visceral leishmaniasis on HIV-1 infection].
    Macías J; Pineda JA; Gallardo JA; Lissen E
    Med Clin (Barc); 1999 Feb; 112(4):157. PubMed ID: 10074637
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical aspects of visceral leishmaniasis in HIV infection.
    Jarvis JN; Lockwood DN
    Curr Opin Infect Dis; 2013 Feb; 26(1):1-9. PubMed ID: 23221770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.